Michael Hill

Active 1970–2025

101
Papers
18,750
Citations
60
h-index
91
i10-index

Citations

Citations per year for Michael Hill1970: 1 citations1983: 1 citations1984: 1 citations1985: 1 citations1986: 1 citations1988: 1 citations1989: 4 citations1990: 3 citations1991: 2 citations1992: 1 citations1993: 2 citations1995: 3 citations1996: 9 citations1997: 23 citations1998: 42 citations1999: 47 citations2000: 63 citations2001: 53 citations2002: 67 citations2003: 84 citations2004: 100 citations2005: 117 citations2006: 107 citations2007: 76 citations2008: 79 citations2009: 53 citations2010: 51 citations2011: 62 citations2012: 95 citations2013: 104 citations2014: 122 citations2015: 86 citations2016: 69 citations2017: 90 citations2018: 91 citations2019: 366 citations2020: 397 citations2021: 367 citations2022: 323 citations2023: 274 citations2024: 513 citations2025: 241 citations2026: 22 citations1971–1982: no citations, so these years are not shown1987: no citations, so this year is not shown1994: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,578 citing papers, 21.1% of this breakdownUnited Kingdom: 783 citing papers, 10.5% of this breakdownChina: 667 citing papers, 8.9% of this breakdownGermany: 351 citing papers, 4.7% of this breakdownNetherlands: 331 citing papers, 4.4% of this breakdownItaly: 327 citing papers, 4.4% of this breakdownAustralia: 298 citing papers, 4% of this breakdownCanada: 292 citing papers, 3.9% of this breakdownFrance: 236 citing papers, 3.1% of this breakdownSweden: 173 citing papers, 2.3% of this breakdownSpain: 158 citing papers, 2.1% of this breakdownJapan: 146 citing papers, 1.9% of this breakdown
0%21.1%Other 28.7%

Fields

  • Medicine69.2%
  • Biochemistry, Genetics and Molecular Biology12.7%
  • Social Sciences3.4%
  • Neuroscience2.8%
  • Immunology and Microbiology2%
  • Health Professions1.8%
  • Other8.1%

Topics

  • Lipoproteins and Cardiovascular Health5.6%
  • Diabetes, Cardiovascular Risks, and Lipoproteins4.2%
  • Cardiac pacing and defibrillation studies3.6%
  • Chronic Kidney Disease and Diabetes2.7%
  • Cardiovascular Function and Risk Factors2%
  • Dialysis and Renal Disease Management1.8%
  • Other80.1%

Coauthors

All papers

Open in search
  1. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Lewis, William G. Herrington, Marion Mafham, William Majoni, Karl Wallendszus, Richard H. Grimm, Terje Pedersen, Jonathan A. Tobert, Jane Armitage, Alex Baxter, Christopher Bray, Yiping Chen, Zhengming Chen, Michael Hill, Carol Knott, Sarah Parish, David Simpson, Peter Sleight, Alan Young, Rory Collins - The Lancet 2011 cited by 2,466

  2. Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke

    Authors: , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2018 cited by 521

  3. Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults

    Authors: , , , , , , , , , , , , , , , , , - Nature Medicine 2019 cited by 331

  4. Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katherine R. Tuttle, Dominik Steubl, Daisy Massey, Martin Landray, Colin Baigent, Richard Haynes, WG Herrington, S Abat, Riaz Rahman, Rizna Abdul Cader, MI Abdul Hafidz, MZ Abdul Wahab, NK Abdullah, Talal Abdulsamad, Masanori Abe, Nader G. Abraham, Sarah Acheampong, P Achiri, JA Acosta, A. Q. Adeleke, Vicki Adell, R Adewuyi-Dalton, Nihad Adnan, A Africano, Mohsen Agharazii, Frank G. Aguilar, A Aguilera, Movahedian Ahmad, MK Ahmad, NA Ahmad, NH Ahmad, NI Ahmad, Norazinizah Ahmad Miswan, H Ahmad Rosdi, Iffat Ahmed, Sofia B. Ahmed, Sofia B. Ahmed, Joan Aiello, A. Aitken, R AitSadi, Sendogan Aker, S Akimoto, A Akinfolarin, S. Akram, Federico Alberici, Christian Albert, Leslie N. Aldrich, M Alegata, Lee Alexander, S Alfaress, Mohammad Alhadj Ali, Ahmed Issam Ali, Ahmed Issam Ali, Radica Z. Alicic, A Aliu, Ricardo López Almaraz, Rashid Almasarwah, Jussara Carnevale de Almeida, Alessia Aloisi, Laith Al‐Rabadi, Mark Dominik Alscher, Pedro Álvarez, Bader Al-Zeer, Mora Amat, Christopher S. Ambrose, Hany Ammar, Yu An, L Andriaccio, Kwame Ansu, A Apostolidi and 1,572 more - The Lancet Diabetes & Endocrinology 2023 cited by 108

  5. The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: a case-cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Lancet Public Health 2021 cited by 195

  6. Genotyping and population characteristics of the China Kadoorie Biobank

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Genomics 2023 cited by 129

  7. Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dominik Steubl, Michaela Petrini, Siegfried Seidi, Martin Landray, Colin Baigent, WG Herrington, Sharirose Abat, Riaz Rahman, Rizna Abdul Cader, MI Abdul Hafidz, MZ Abdul Wahab, NK Abdullah, Talal Abdulsamad, Masami Abe, Ned Abraham, Sarah Acheampong, P Achiri, JA Acosta, A A Adeleke, Vicki Adell, R Adewuyi-Dalton, Nihad Adnan, A Africano, Mohsen Agharazii, Frank G. Aguilar, A Aguilera, M Ahmad, MK Ahmad, NA Ahmad, NH Ahmad, NI Ahmad, Norazinizah Ahmad Miswan, H Ahmad Rosdi, Iffat Ahmed, Sofia B. Ahmed, Sofia B. Ahmed, Joan Aiello, Alastair Aitken, R AitSadi, Sendogan Aker, S Akimoto, Akinwande A. Akinfolarin, S. Akram, Federico Alberici, Christian Albert, Luke Aldrich, M Alegata, Lacy M. Alexander, S Alfaress, Mohammad Alhadj Ali, A Ali, A Ali, Radica Z. Alicic, Arta Aliu, Ricardo López Almaraz, Rashid Almasarwah, Jussara Carnevale de Almeida, Alessia Aloisi, Laith Al‐Rabadi, Mark Dominik Alscher, Pedro Álvarez, Bader Al-Zeer, M. Ochoa de Olza Amat, Christopher S. Ambrose, Hany Ammar, Yu An, L Andriaccio, K Ansu, A Apostolidi, N. Arai and 1,571 more - The Lancet Diabetes & Endocrinology 2023 cited by 90

  8. Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease

    Authors: , , , , , , , , , , , , , , , , - Circulation 2018 cited by 245

  9. Perioperative Rosuvastatin in Cardiac Surgery

    Authors: , , , , , , , , , , , - New England Journal of Medicine 2016 cited by 313

  10. Identification of host–pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew J. Pollard, Thomas F. Schulz, Kate Soldan, Graham P. Taylor, Greg J. Towers, Massimo Tommasino, Robin A. Weiss, Denise Whitby, C. Wild, David Wyllie, Rory Collins, Adrian V. S. Hill, Tim Waterboer - Nature Communications 2022 cited by 110

  11. Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rory Collins, Liming Li, Chen Wang, Jun Lv, Richard Peto, Robin Walters, Daniel Avery, Maxim Barnard, Derrick Bennett, Ruth Boxall, Sushila Burgess, Ka Hung Chan, Yiping Chen, Zhengming Chen, Johnathan Clarke, Robert Clarke, Huaidong Du, Ahmed Edris Mohamed, Hannah Fry, Simon Gilbert, Pek Kei Im, Andri Iona, Maria Kakkoura, Christiana Kartsonaki, Hubert Lam, Kuang Lin, James H. Liu, Mohsen Mazidi, Iona Y. Millwood, Sam Morris, Qunhua Nie, Alfred Pozarickij, Paul Ryder, Saredo Said, Dan Schmidt, Becky Stevens, Iain Turnbull, Robin Walters, Baihan Wang, Lin Wang, Neil Wright, Ling Yang, Xiaoming Yang, Pang Yao, Xiao Han, Can Hou, Qingmei Xia, Chao Liu, Jun Lv, Pei Pei, Dianjanyi Sun, Canqing Yu, Naying Chen, Duo Liu, Zhenzhu Tang, Ningyu Chen, Qilian Jiang, Jian Lan, Mingqiang Li, Yun Liu, Fanwen Meng, Jinhuai Meng, Rong Pan, Yulu Qin, Ping Wang, Sisi Wang, Liuping Wei, Liyuan Zhou, Caixia Dong, Pengfei Ge and 95 more - Journal of the American College of Cardiology 2023 cited by 39

  12. HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M. Lay, Christopher Bray, E. Wincott, G. van Leijenhorst, A. Skattebøl, Gro Kvelprud Moen, Yale Mitchel, O. Kuznetsova, Stephen MacMahon, John Kjekshus, Catherine J. Hill, TH Lam, Peter Sandercock, Richard Peto, Jemma C. Hopewell - European Heart Journal 2013 cited by 673

  13. Theta-burst microstimulation in the human entorhinal area improves memory specificity

    Authors: , , , , , , , , , , , , - eLife 2017 cited by 126

  14. Diabetes and Cause-Specific Mortality in Mexico City

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2016 cited by 282

  15. Association of CETP Gene Variants With Risk for Vascular and Nonvascular Diseases Among Chinese Adults

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - JAMA Cardiology 2017 cited by 82

  16. Effects of Lowering LDL Cholesterol on Progression of Kidney Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lawrence Y. Agodoa, Mike Gaziano, Bertram L. Kasiske, Rob Walker, Ziad A. Massy, Bo Feldt‐Rasmussen, Udom Krairittichai, Vuddidhej Ophascharoensuk, Bengt Fellström, Hallvard Holdaas, Vladimı́r Tesař, Andrzej Więcek, Diederick E. Grobbee, Dick de Zeeuw, Carola Grönhagen‐Riska, Tanaji Dasgupta, David Lewis, William G. Herrington, Marion Mafham, William Majoni, Karl Wallendszus, Richard H. Grimm, Terje Pedersen, Jonathan A. Tobert, Jane Armitage, Alex Baxter, Christopher Bray, Yiping Chen, Zhengming Chen, Michael Hill, Carol Knott, Sarah Parish, David Simpson, Peter Sleight, Alan Young, Rory Collins - Journal of the American Society of Nephrology 2014 cited by 177

  17. Apolipoprotein Proteomics for Residual Lipid-Related Risk in Coronary Heart Disease

    Authors: , , , , , , , , , , , , - Circulation Research 2023 cited by 45

  18. STREET‐LEVEL BUREAUCRACY AND PUBLIC ACCOUNTABILITY

    Authors: , - Public Administration 2007 cited by 833

  19. Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study

    Authors: , , , , , , , , , , , - Circulation Genomic and Precision Medicine 2018 cited by 93

  20. Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip J. Barter, Borislava Mihaylova, Yale Mitchel, Robert O. Blaustein, Seiichi Goto, Jonathan A. Tobert, Paul DeLucca, Y Chen, Z Chen, Alastair Gray, Richard Haynes, Jane Armitage, Colin Baigent, Stephen D. Wiviott, Christopher P. Cannon, Eugene Braunwald, Rory Collins, Louise Bowman, Martin Landray, REVEAL Collaborative Group - European Heart Journal 2021 cited by 62

  21. Circulating Metabolites and the Development of Type 2 Diabetes in Chinese Adults

    Authors: , , , , , , , , , , , , , , , , , , - Diabetes Care 2021 cited by 49

  22. Circulating proteins and risk of pancreatic cancer: a case-subcohort study among Chinese adults

    Authors: , , , , , , , , , , , , , , , , , - International Journal of Epidemiology 2021 cited by 24

  23. Association of vitamin D with risk of type 2 diabetes: A Mendelian randomisation study in European and Chinese adults

    Authors: , , , , , , , , , , , , , , , , , - PLoS Medicine 2018 cited by 115

  24. Approaches to minimising the epidemiological impact of sources of systematic and random variation that may affect biochemistry assay data in UK Biobank

    Authors: , , , , , , , , , , , - Wellcome Open Research 2020 cited by 56